FOOD TOXINS, AMPA RECEPTORS, AND MOTOR NEURON DISEASES*

REFERENCES

• Spencer P. S. Lathyrism. Handbook of Clinical Neurology, Intoxications of the Nervous System, Part II, F. A. de Wolff. Elsevier, Amsterdam 1995; 21: 1–20
   Google Scholar
• Rosling H., Tylleskär T. Cassava. Experimental and Clinical Neurotoxicology, P. S. Spencer, H. H. Schaumberg. Oxford University Press, New York 1999; 338–343
   Google Scholar
• Watkins J. C., Evans R. H. Excitatory amino acid transmitters. Annu. Rev. Pharmacol. Toxicol. 1981; 21: 165–204
   PubMed Web of Science ®Google Scholar
• Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 1994; 17: 31–108
   PubMed Web of Science ®Google Scholar
• Choi. D. W. Calcium: Still center-stage in hypoxic–ischemic neuronal death. Trends Neurosci. 1995; 18: 58–60
   PubMed Web of Science ®Google Scholar
• Olney J. W., Ludolph A. C. Excitotoxic mechanisms of neurotoxicity. Experimental and Clinical Neurotoxicology, P. S. Spencer, H. H. Schaumburg. Oxford University Press, New York 1999; 604–610
   Google Scholar
• Yu S. P., Yeh C.-H., Strasser U., Tian M., Choi D. W. NMDA receptor-mediated K+ efflux and neuronal apoptosis. Science 1999; 284: 336–339
   PubMed Web of Science ®Google Scholar
• Teitelbaum J. S., Zatorre R. J., Carpenter S., Gendron D., Evans A. C., Gjedde A., Cashman N. R. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. New Engl. J. Med., 322: 1781–1787
   PubMed Web of Science ®Google Scholar
• Scallet A. C., Binienda Z., Caputo F. A., Hall S., Paule M. G., Rountree R. L., Schmued L., Sobotka T., Slikker W., Jr. Domoic acid-treated cynomolgus monkeys (M. fascicularis): Effects of dose on hippocampal neuronal and terminal degeneration. Brain Res. 1993; 627: 307–313
   PubMed Web of Science ®Google Scholar
• Tryphonas L., Truelove J., Todd E., Nera E., Iverson F. Experimental oral toxicity of domoic acid in cynomolgus monkeys (Macaca fascicularis) and rats. Preliminary investigations. Food Chem. Toxicol. 1990; 28: 707–715
   PubMed Web of Science ®Google Scholar
• Hugon J., Vallat J. M., Spencer P. S., Leboutet M. J., Barthe D. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci. Lett. 1989; 104: 258–262
   PubMed Web of Science ®Google Scholar
• Shaw P. J., Williams T. L., Slade J. Y., Eggett C. J., Ince P. G. Low expression of GluR2 AMPA receptor subunit protein by human motor neurons. Neuroreport 1999; 10: 261–265
   PubMed Web of Science ®Google Scholar
• Jakowec M. W., Yen L., Kalb R. G. In situ hybridization analysis of AMPA receptor subunit gene expression in the developing rat spinal cord. Neuroscience 1995; 67: 909–920
   PubMed Web of Science ®Google Scholar
• Tolle T. R., Berthele A., Zieglgansberger W., Seeburg P. H., Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci. 1993; 13: 5009–5028
   PubMed Web of Science ®Google Scholar
• Geiger J. R., Melcher T., Koh D. S., Sakmann B., Seeburg P. H., Jonas P., Monyer H. Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 1995; 15: 193–204
   PubMed Web of Science ®Google Scholar
• Jonas P., Burnashev N. Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron 1995; 15: 987–990
   PubMed Web of Science ®Google Scholar
• Burke S. J., Yin H. Z., Weiss J. H. Ca2+ and in vitro kainate damage to cortical and hippocampal SMI-32(+) neurons. Neuroreport 1995; 6: 629–632
   PubMed Web of Science ®Google Scholar
• Carriedo S. G., Yin H. Z., Lamberta R., Weiss J. H. In vitro kainate injury to large, SMI-32(+) spinal neurons is Ca2+ dependent. Neuroreport 1995; 6: 945–948
   PubMed Web of Science ®Google Scholar
• Feldmeyer D., Kask K., Brusa R., Kornau H.-C., Kolhekar R., Rozov A., Burnashev N., Jensen V., Hvalby Ø., Sprengel R., Seeburg P. H. Neurological dysfunctions in mice expressing different levels of the Q-R site-unedited AMPAR subunit GluR-B. Nature Neurosci. 1999; 2: 57–64
   PubMed Web of Science ®Google Scholar
• Kessler A. Lathyrismus. Monatsschr. Psychiatr. Neurol. 1947; 113: 345–375
   PubMedGoogle Scholar
• Ludolph A. C., Hugon J., Dwivedi M. P., Schaumburg H. H., Spencer P. S. Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: Clinical findings in established cases. Brain 1987; 110: 149–165
   PubMed Web of Science ®Google Scholar
• Tekle-Haimanot R., Kidane Y., Wuhib E., Kalissa A., Alemu T., Zein Z. A., Spencer P. S. Lathyrism in rural northwestern Ethiopia: A highly prevalent neurotoxic disorder. Int. J. Epidemiol. 1990; 19: 664–672
   PubMed Web of Science ®Google Scholar
• Hugon J., Ludolph A. C., Spencer P. S., Gimenez-Roldan S., Dumas J. L. Studies on the etiology and pathogenesis of motor neuron diseases. III. Magnetic cortical stimulation in patients with lathyrism. Acta Neurol. Scand. 1993; 88: 412–416
   PubMed Web of Science ®Google Scholar
• Gimenez-Roldan S., Ludolph A. C., Hugon J., Hens M., Mateo D., Kisby G. E., Spencer P. S. Lathyrism in Spain: Progressive central nervous system deficits more than 45 years after onset?. Nutrition, Neurotoxins, and Lathyrism. The ODAP Challenge, B. N. Abegaz, R. Tekle-Haimanot, V. P. Palmer, P. S. Spencer. Third World Medical Research Foundation, New York 1994; 10–25
   Google Scholar
• Tekle-Haimanot R., Kidane Y., Wuhib E., Kassina A., Endeshaw Y., Alemu T., Spencer P. S. The epidemiology of lathyrism in north and central Ethiopia. J. Ethiop. Med. 1993; 31: 15–24
   PubMed Web of Science ®Google Scholar
• Tekle-Haimanot R., Abegaz B. M., Wuhib E., Kassina A., Kidane Y., Kebede N., Alemu T., Spencer P. S. Pattern of Lathyrus sativus (grass pea) consumption and β-N-oxalyl-α,β-diaminoproprionic acid (β-ODAP) content of food samples in the lathyrism endemic region of northwest Ethiopia. Nutr. Res. 1993; 13: 1113–1126
   Web of Science ®Google Scholar
• Spencer P. S., Roy D. N., Ludolph A., Hugon J., Dwivedi M. P., Schaumburg H. H. Lathyrism: Evidence for role of the neuroexcitatory amino acid BOAA. Lancet, ii 1986; 1066–1067
   PubMed Web of Science ®Google Scholar
• Roy D. N., Kisby G. E., Robertson R. C., Spencer P. S. Toxicology of Lathyrus sativus and the neurotoxin BOAA. The Grass Pea: Threat and Promise, P. S. Spencer. Third World Medical Research Foundation, New York 1989; 76–85
   Google Scholar
• Gilman S. Primate models of postural abnormalities. Primate Models of Neurological Disorders, B. S. Meldrum, C. D. Marsden. Raven Press, New York 1975; 55–76
   Google Scholar
• Hugon J., Ludolph A. C., Spencer P. S., Roldan S. Gimenez, Dumas J. L. Studies of the etiology and pathogenesis of motorneuron diseases. III. Magnetic cortical stimulation in patients with lathyrism. Acta Neurol. Scand. 1993; 88: 412–416
   PubMed Web of Science ®Google Scholar
• Ross S. M., Spencer P. S. Specific antagonism of behavioral action of “uncommon” amino acids linked to motor-system disease. Synapse 1987; 1: 248–253
   PubMed Web of Science ®Google Scholar
• Ross S. M., Seelig M., Spencer P. S. Specific antagonism of excitotoxic action of “uncommon” amino acids assayed in organotypic mouse cortical cultures. Brain Res. 1987; 425: 120–177
   PubMed Web of Science ®Google Scholar
• Nunn P. B., Seelig M., Zagoren J. C., Spencer P. S. Stereospecific acute neuronotoxicity of “uncommon” plant amino acids linked to human motor-system diseases. Brain Res. 1987; 410: 375–379
   PubMed Web of Science ®Google Scholar
• Ross S. M., Roy D. N., Spencer P. S. β-N-Oxalylamino-L-alanine: Action on high-affinity transport of neurotransmitters in rat brain and spinal cord synaptosomes. J. Neurochem. 1985; 53: 710–715
   Google Scholar
• Ross S. M., Roy D. N., Spencer P. S. β-N-Oxalylamino-L-alanine action of glutamate receptors. J. Neurochem. 1989; 53: 710–715
   PubMed Web of Science ®Google Scholar
• Honoré T., Nielsen M. Complex structure of quisqualate-sensitive glutamate receptors in rat cortex. Neurosci. Lett. 1995; 54: 27–32
   Google Scholar
• Honoré T., Drejer J. Chaotropic ions affect the conformation of quisqualate receptors in rat cortical membranes. J. Neurochem. 1988; 51: 457–461
   PubMed Web of Science ®Google Scholar
• Ross S. M., Spencer P. S. Excitotoxic principles of plants linked to neuronal disease involving motor and other systems. Frontiers in Excitatory Amino Acids Research, J. L. Lehman. Alan R. Liss, New York 1988; 517–524
   Google Scholar
• Acta Horticult, M. Bokanga, A. J. A. Essers, N. Poulter, H. Rosling, O. Tewe, 1994; 375
   Google Scholar
• Roman G. C., Spencer P. S., Schoenberg B. S. Tropical myeloneuropathies: The hidden endemias. Neurology 1985; 35: 1158–1170
   PubMed Web of Science ®Google Scholar
• Tylleskär T., Rwiza H. T., Banea M., Howlett W. P., Aquilonius S.-M., Pearson L.-A., Rosling H. Similarities between konzo and lathyrism suggest a common pathogenetic mechanism. Nutrition, Neurotoxins, and Lathyrism, The ODAP Challenge, B. Abegaz, R. T. Haimanot, V. S. Palmer, P. S. Spencer. Third World Medical Research Foundation, New York 1994; 26–32
   Google Scholar
• Spencer P. S. Human consumption of plant materials with neurotoxic potential. Acta Horticult. 1994; 375: 341–348
   Google Scholar
• Tewe O. O., Iyayi E. A. Cyanogenic glucosides. Toxicants of Plant Origin, Vol. II, Glycosides, P. R. Cheeke. CRC Press, Boca Raton, FL 1989; 43–60
   Google Scholar
• O’Brien G. M., Mbome L., Taylor A. J., Poulter N. H. Variations in cyanogen content of cassava during village processing in Cameroon. Food Chem. 1992; 44: 131–136
   Web of Science ®Google Scholar
• Selmar D. Translocation of cyanogenic glucosides in cassava. Acta Horticult. 1994; 375: 61–67
   Google Scholar
• Cliff J. L. Cassava safety in times of war and drought in Mozambique. Acta Horticult. 1994; 375: 373–378
   Google Scholar
• Trolli G. Paraplégie spastique épidémique, konzo, des indigeènes du Kwango. Résumé des Observations Reuniues, au Kwango, au Sujet de Deux Affections d’Origine Indéterminéé. Fonds Reine Elisabeth, Brussels 1938; 1–36
   Google Scholar
• Ministry of Health Mozambique, Mantakassa: An epidemic of spastic paraparesis associated with chronic cyanide intoxication in a cassava staple area in Mozambique. 1. Epidemiology and clinical and laboratory findings in patients. Bull. World Hlth. Org. 1984; 62: 477–484
   PubMed Web of Science ®Google Scholar
• Ministry of Health Mozambique, Mantakassa: An epidemic of spastic paraparesis associated with chronic cyanide intoxication in a cassava staple area in Mozambique, 2. Nutritional factors and hydrocyanic content of cassava plants. Bull. World Hlth. Org. 1984; 62: 485–492
   PubMed Web of Science ®Google Scholar
• Howlett W. P. Konzo: A new human disease entity. Acta Horticult. 1994; 375: 323–329
   Google Scholar
• Tylleskär T., Banea M., Bikangi N., Cooke R., Poulter N., Rosling H. Cassava cyanogens and konzo, an upper motor neuron disease found in Africa. Lancet 1992; 339: 208–211
   PubMed Web of Science ®Google Scholar
• Tylleskär T., Howlett W. P., Rwiza H. T., Aquilonius S. M., Stalberg E., Linden B., Mandahl A., Larsen H. C., Brubaker G. R., Rosling H. Konzo: A distinct disease entity with selective upper motor neuron damage. J. Neurol. Neurosurg. Psychiat. 1993; 56: 638–643
   PubMed Web of Science ®Google Scholar
• Swenne I., Eriksson U. J., Christoffersson R., Kagedal B., Lundquist P., Nilsson L., Tylleskär T., Rosling H. Cyanide detoxification in rats exposed to acetonitrile and fed a low protein diet. Fundam. Appl. Toxicol. 1996; 32: 66–71
   PubMedGoogle Scholar
• Tor-Agbidye J., Palmer V. S., Sabri M. I., Craig A. M., Blythe L. L., Spencer P. S. Dietary deficiency of cystine and methionine in rats alters thiol homeostasis required for cyanide detoxification. J. Toxicol. Environ. Hlth. 1998; 55: 583–595
   PubMed Web of Science ®Google Scholar
• Tor-Agbidye J., Palmer V. S., Lasarev M. R., Craig A. M., Blythe L. L., Sabri M. I., Spencer P. S. Bioactivation of cyanide to cyanate in sulfur amino acid deficiency: Relevance to neurological disease in humans subsisting on cassava. Toxicol. Sci., in press
   Web of Science ®Google Scholar
• Lundquist P., Kagedal B., Nilsson L., Rosling H. Analysis of the cyanide metabolite 2-aminothiazoline-4-carboxylic acid in urine by high-performance liquid chromatography. Anal. Biochem. 1995; 228: 27–34
   PubMed Web of Science ®Google Scholar
• Bitner R. S., Yim G. K., Isom G. E. 2-Iminothiazolidine-4-carboxylic acid produces hippocampal CA1 lesions independent of seizure excitation and glutamate receptor activation. Neurotoxicology 1997; 18: 191–200
   PubMed Web of Science ®Google Scholar
• Uitti R. J., Rajput A. H., Ashenhurst E. M., Rozdilsky B. Cyanide-induced parkinsonism: A clinicopathologic report. Neurology 1985; 35: 921–925
   PubMed Web of Science ®Google Scholar
• Carella F., Grassi M., Savoiardo M., Contri P., Rapuzzi B., Magnoni A. Dystonic-parkinsonian syndrome after cyanide poisoning: Clinical and MRI findings. J. Neurol. Neurosurg. Psychiat. 1988; 51: 1345–1348
   PubMed Web of Science ®Google Scholar
• Messing B., Storch B. Computer tomography and magnetic resonance imaging in cyanide poisoning. Eur. Arch. Psychiat. Neurol. Sci. 1988; 237: 139–143
   PubMedGoogle Scholar
• Grandas F., Artieda J., Obeso J. A. Clinical and CT scan findings in a case of cyanide intoxication. Movement Disord. 1989; 4: 188–193
   PubMed Web of Science ®Google Scholar
• Feldman J. M., Feldman M. D. Sequelae of attempted suicide by cyanide ingestion: A case report. Int. J. Psychiat. Med. 1990; 20: 173–179
   PubMed Web of Science ®Google Scholar
• Inoue N. Extrapyramidal syndrome induced by chemical substances. Nippon Rinsho 1993; 51: 2924–2928, in Japanese
   PubMedGoogle Scholar
• Rosenberg N. L., Myers J. A., Martin W. R. Cyanide-induced parkinsonism: Clinical, MRI, and 6-fluorodopa PET studies. Neurology 1989; 39: 142–144
   PubMed Web of Science ®Google Scholar
• Novelli A., Reilly J. A., Lysko P. G., Henneberry R. C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 1988; 451: 205–212
   PubMed Web of Science ®Google Scholar
• Patel M. N., Yim G. K., Isom G. E. N-Methyl-D-aspartate receptors mediate cyanide-induced cytotoxicity in hippocampal cultures. Neurotoxicology 1993; 14: 35–40
   PubMed Web of Science ®Google Scholar
• Patel M. N., Peoples R. W., Yim G. K., Isom G. E. Enhancement of NMDA-mediated responses by cyanide. Neurochem. Res. 1994; 19: 1319–1323
   PubMed Web of Science ®Google Scholar
• Bitner R. S., Kanthasamy A., Isom G. E., Yim G. K. Seizures and selective CA-1 hippocampal lesions induced by an excitotoxic cyanide metabolite, 2-iminothiazolidine-4-carboxylic acid. Neurotoxicology 1995; 16: 115–122
   PubMed Web of Science ®Google Scholar
• Koshiishi I., Imanari T. State analysis of endogenous cyanate ion in human plasma. J. Pharmacobiodyn. 1990; 13: 254–258
   PubMedGoogle Scholar
• Kraus L. M., Kraus A. P., Jr. The search for the uremic toxin: The case for carbamoylation of amino acids and proteins. Wien Klin. Wochenschr. 1998; 110: 521–530
   PubMed Web of Science ®Google Scholar
• Gonzalez C., Farias G., Maccioni R. B. Modification of tau to an Alzheimer’s type protein interferes with its interaction with microtubules. Cell. Mol. Biol. (Noisy-Le-Grand) 1998; 44: 1117–1127
   PubMed Web of Science ®Google Scholar
• Kuckel C. L., Lubit B. W., Lambooy P. K., Farnsworth P. Methylisocyanate and actin polymerization: The in vitro effects of carbamylation. Biochim. Biophys. Acta 1993; 5: 143–148
   Google Scholar
• Samson F. E., Jr., Hinkley R. E., Jr. Neuronal microtubular systems. Anesthesiology 1972; 36: 417–421
   PubMed Web of Science ®Google Scholar
• Bradley W. G. The neuromyopathy of vincristine-induced peripheral neuropathy. Ann. Neurol. 1977; 1: 255
   PubMed Web of Science ®Google Scholar
• Green L. S., Donoso J. A., Heller-Bettinger I. E., Samson F. E. Axonal transport disturbance in vincristine-induced peripheral neuropathy. Ann. Neurol. 1977; 1: 255–262
   PubMed Web of Science ®Google Scholar
• Cerami A., Allen A. T., Graziano J. H., Derfuria F. G., Manning J. M., Gillente P. N. Pharmacology of cyanate, 1. General effects on experimental animals. J. Pharmacol. Exp. Therap. 1973; 185: 653–666
   PubMed Web of Science ®Google Scholar
• Alter B. P., Kan Y. W., Nathan D. G. Toxic effects of high-dose cyanate administration in rodents. Blood 1974; 1: 69–77
   Google Scholar
• Peterson C. M., Tsairus P., Ohnishi A., Lu Y. S., Grady R., Cerami A. Sodium cyanate induced polyneuropathy in patients with sickle-cell disease. Ann. Intern. Med. 1974; 81: 152–158
   PubMed Web of Science ®Google Scholar
• Ohnishi A., Peterson C. M., Dyck P. J. Axonal degeneration in sodium cyanate-induced neuropathy. Arch. Neurol. 1975; 32: 530–534
   PubMed Web of Science ®Google Scholar
• Asbury A. K., Victor M., Adams R. D. Uremic polyneuropathy. Arch. Neurol. 1963; 8: 413–428
   PubMed Web of Science ®Google Scholar
• Thomas P. K., Hollinrake K., Lascelles R. G., O’Sullivan D. J., Baillod R. A., Moorhead J. F., Mackenzie J. C. The polyneuropathy of chronic renal failure. Brain 1971; 94: 761–780
   PubMed Web of Science ®Google Scholar
• Kraus L. M., Kraus A. P., Jr. The search for the uremic toxin: The case for carbamoylation of amino acids and proteins. Wien Klin. Wochenschr. 1998; 110: 521–530
   PubMed Web of Science ®Google Scholar
• Shaw C.-M., Papayannopoulou T., Stamatoyannopoulus G. Neuropathology of cyanate toxicity in rhesus monkeys. Preliminary report. Pharmacology 1974; 12: 166–176
   PubMed Web of Science ®Google Scholar
• Tor-Agbidye J., Palmer V. S., Spencer P. S., Craig A. M., Blythe L. L., Sabri M. I. Sodium cyanate alters glutathione homeostasis in rodent brain: Relationship to neurodegenerative diseases in protein-deficit malnourished populations in Africa. Brain Res. 1999; 820: 12–19
   PubMed Web of Science ®Google Scholar
• Arai A., Silberg J., Kessler M., Lynch G. Effect of thiocyanate on AMPA receptor mediated responses in excised patches and hippocampal slices. Neuroscience 1995; 66: 815–827
   PubMed Web of Science ®Google Scholar
• Nielsen E. O., Johansen T. H., Watjen F., Drejer J. Characterization of the binding of [3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections. J. Neurochem. 1995; 65: 1264–1273
   PubMed Web of Science ®Google Scholar
• Hawkinson J. E., Espitia J. E. Effects of thiocyanate and AMPA receptor ligands on (S)-5-fluorowillardiine, (S)-AMPA and (R,S)-AMPA high-performance liquid chromatography. Anal. Biochem. 1997; 10: 27–34
   Google Scholar
• Murphy D. E., Snowhill E. W., Williams M. Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay. Neurochem., Res. 1987; 12: 775–781
   PubMed Web of Science ®Google Scholar
• Nielsen E. O., Cha J. H., Honoré T., Penney J. B., Young A. B. Thiocyanate stabilizes AMPA binding to the quisqualate receptor. Eur. J. Pharmacol. 1988; 157: 197–203
   PubMed Web of Science ®Google Scholar
• Baudry M., Monaghan D., Cotman C., Altar C. A. Regional distribution of binding. Eur. Pharmacol. 1988; 54: 1682–1688
   Google Scholar
• Hall R. A., Massicotte G., Kessler M., Baudry M., Lynch G. Thiocyanate equally increases affinity for two DL-α-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states. Mol. Pharmacol. 1993; 43: 459–464
   PubMed Web of Science ®Google Scholar
• Shahi K., Baudry M. Increasing binding affinity of agonists to glutamate receptors increases synaptic responses at glutamatergic synapses. Proc. Natl. Acad. Sci. USA 1992; 89: 6881–6885
   PubMed Web of Science ®Google Scholar
• Cha J. H., Makowiec R. L., Penney J. B., Young A. B. Multiple states of rat brain, (RS)-α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors as revealed by quantitative autoradiography. Mol. Pharmacol. 1992; 41: 832–838
   PubMed Web of Science ®Google Scholar
• Hall R. A., Massicotte G., Kessler M., Baudry M., Lynch G. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states. Mol. Pharmacol. 1993; 43: 459–464
   PubMed Web of Science ®Google Scholar
• Pai K. S., Ravindranath V. L-BOAA induces selective inhibition of brain mitochondrial enzyme, NADH-dehydrogenase. Brain Res. 1993; 621: 215–221
   PubMed Web of Science ®Google Scholar
• Sabri M. I., Roy D. N., Lystrup B., Allen C. N., Spencer P. S. Action of β-N-oxalylamino-L-alanine on mouse brain. J. Neurochem., 65: 1842–1848
   Google Scholar
• Tamaru M., Yoneda Y., Ogita K., Shimizu J., Nagata Y. Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res. 1991; 22: 83–90
   Google Scholar
• Ludolph A. C., Spencer P. S. Toxic models of upper motor neuron disease. J. Neurol. Sci. 1996; 139(Suppl.)53–59
   PubMedGoogle Scholar
• Ames B. N., Gold L. S. The prevention of cancer. Drug Metab. Rev. 1990; 30: 201–223
   Google Scholar